Rough titanium surfaces enhance the activation of Wnt canonical signaling, a pathway required for osteoblast differentiation. The present study investigated the effects of GSK3b-inhibitor (2’Z,3’E)- hydrophilic SLA titanium discs (modSLA) and stimulated with increasing doses of BIO. Activation of same cell system by Real Time PCR. Osteoblastic MC3T3 cells were then plated on discs with or without activated Wnt canonical signaling in C2C12 cells on all surfaces, and the highest effect was on rough rough surfaces at the concentration of 100 nM, and on all surfaces at the concentration of 1 mM. BIO be a viable approach to improve cell response to implant surfaces.

Pharmacological GSK-3beta inhibition improves osteoblast differentiation on titanium surfaces / Lumetti, S; Ferrillo, S; Mazzotta, S; Macaluso, Gm; Bonanini, M; Passeri, G; Galli, C.. - In: JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS. - ISSN 0393-974X. - 28:3(2014), pp. 489-495.

Pharmacological GSK-3beta inhibition improves osteoblast differentiation on titanium surfaces.

LUMETTI, Simone;MACALUSO, Guido Maria;BONANINI, Mauro;PASSERI, Giovanni;GALLI, Carlo
2014

Abstract

Rough titanium surfaces enhance the activation of Wnt canonical signaling, a pathway required for osteoblast differentiation. The present study investigated the effects of GSK3b-inhibitor (2’Z,3’E)- hydrophilic SLA titanium discs (modSLA) and stimulated with increasing doses of BIO. Activation of same cell system by Real Time PCR. Osteoblastic MC3T3 cells were then plated on discs with or without activated Wnt canonical signaling in C2C12 cells on all surfaces, and the highest effect was on rough rough surfaces at the concentration of 100 nM, and on all surfaces at the concentration of 1 mM. BIO be a viable approach to improve cell response to implant surfaces.
Pharmacological GSK-3beta inhibition improves osteoblast differentiation on titanium surfaces / Lumetti, S; Ferrillo, S; Mazzotta, S; Macaluso, Gm; Bonanini, M; Passeri, G; Galli, C.. - In: JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS. - ISSN 0393-974X. - 28:3(2014), pp. 489-495.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2801112
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 7
social impact